Affordable Access

deepdyve-link
Publisher Website

Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations

Authors
  • Gabriel J Escobar
  • Tebeb Gebretsadik
  • Kecia Carroll
  • Sherian Li
  • Eileen Walsh
  • Pingsheng Wu
  • Ed Mitchel
  • Chantel Sloan
  • Tina Hartert
Type
Published Article
Journal
Journal of the Pediatric Infectious Diseases Society
Publisher
Oxford University Press
Volume
2
Issue
3
Pages
205–214
Identifiers
DOI: 10.1093/jpids/pit007
Source
Kaiser Perinatal
License
White

Abstract

Immunoprophylaxis is the only pharmaceutical intervention for mitigating respiratory syncytial virus (RSV) infection. Patient level data on adherence to American Academy of Pediatrics (AAP) immunoprophylaxis recommendations are limited. This study characterizes adherence to AAP guidelines in privately insured and Medicaid populations

Report this publication

Statistics

Seen 191 times